-transparent.png){kind=logo}
Plasma carbonic anhydrase III (CAIII) levels determined by radioimmunoassay have been compared, in detail, with creatine kinase (CK) as indices of Duchenne muscular dystrophy (DMD). CAIII levels were markedly elevated in all patients but variability of levels in a number of individual patients was higher than CK.
Related Publications
N D Carter, and
R Heath, and
S Jeffery, and
M J Jackson, and
D J Newham, and
R H Edwards
February 1985,
Journal of the neurological sciences,
N D Carter, and
R Heath, and
S Jeffery, and
M J Jackson, and
D J Newham, and
R H Edwards
September 1985,
Rinsho shinkeigaku = Clinical neurology,
N D Carter, and
R Heath, and
S Jeffery, and
M J Jackson, and
D J Newham, and
R H Edwards
January 1986,
Muscle & nerve,
N D Carter, and
R Heath, and
S Jeffery, and
M J Jackson, and
D J Newham, and
R H Edwards
January 1991,
Clinical chemistry,
N D Carter, and
R Heath, and
S Jeffery, and
M J Jackson, and
D J Newham, and
R H Edwards
June 1991,
Current opinion in genetics & development,
N D Carter, and
R Heath, and
S Jeffery, and
M J Jackson, and
D J Newham, and
R H Edwards
June 1999,
Thorax,
N D Carter, and
R Heath, and
S Jeffery, and
M J Jackson, and
D J Newham, and
R H Edwards
January 2008,
Neurology India,
N D Carter, and
R Heath, and
S Jeffery, and
M J Jackson, and
D J Newham, and
R H Edwards
January 1995,
The Southeast Asian journal of tropical medicine and public health,
N D Carter, and
R Heath, and
S Jeffery, and
M J Jackson, and
D J Newham, and
R H Edwards
June 2014,
BMJ case reports,
N D Carter, and
R Heath, and
S Jeffery, and
M J Jackson, and
D J Newham, and
R H Edwards
March 2006,
Pediatrics in review,
